Genus PLC (GENS.L)
28 Sep 2016
* Fy adjusted pretax profit rose 7 percent to 49.7 million stg
* Signs exclusive licence for technology to combat Bovine Respiratory Disease
LONDON British animal genetics firm Genus is diving deeper into the hot area of gene editing, in a move Chief Executive Karim Bitar says will bring long-term gains at the cost of a hefty hike in research spending.
* Exclusive licence for leading gene editing tech Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)